Background. Individuals at average risk for colorectal cancer (CRC) have multiple test options. Preference for a specific test modality may affect decision making about CRC screening. The current study examined 1) the sociodemographic and health belief characteristics of average-risk participants with a test preference for stool blood test (SBT) versus those with a preference of colonoscopy, and following receipt of a tailored CRC screening intervention, 2) the percentage of participants who completed a preference-concordant CRC screening test, and 3) the sociodemographic, health care experience, and health belief characteristics and intervention group(s) associated with completion of a preference-concordant screening test. Methods. Participants (N = 603) were female, aged 50 to 75 years, at average CRC risk, not currently up-to-date with CRC screening recommendations, had Internet access, and were randomized to receive 1 of 3 tailored CRC screening promotion interventions. Multivariable logistic regression analyses were conducted. Results. Most women (64%) preferred SBT, whereas 36% preferred colonoscopy. There were significant differences in test preference by age, stage of change for the specific tests, perceived benefits of CRC screening, perceived barriers to both tests, and self-efficacy for colonoscopy. Two hundred thirty participants completed CRC screening at 6 months post-intervention. Of those, most (84%) completed a test concordant with their preference. Multivariable analyses revealed that compared with participants completing a preference-discordant test, those completing a preference-concordant test were older (P = 0.01), had health insurance (P \ 0.05), and were in the phone counseling-only group (P \ 0.01). Conclusions. High levels of completion of preference-concordant CRC screening can be achieved by educating average-risk patients about the multiple screening test options, soliciting their preferences, and offering testing that is concordant with their preference.
should start at age 50. 2 Individuals at average risk for CRC have multiple options regarding which CRC test they can complete, whereas colonoscopy is recommended for those at increased risk. 2 Thus, average-risk individuals have 2 decisions to make: first, whether to complete a CRC screening test and then which CRC test to complete.
In 2015, only 63% of US adults were up-to-date with CRC screening recommendations. 3 Of those up-to-date, 60.3% completed an endoscopic screening (i.e., colonoscopy in the past 10 years or sigmoidoscopy in the past 5 years), and 7.2% completed a stool blood test (SBT; i.e., fecal immunochemical test or fecal occult blood test). 3 However, there are notable disparities in CRC screening completion. For example, white and black adults are more likely than individuals of Hispanic, Asian, or American Indian/Alaska Native descent to complete CRC screening. 3 In addition, younger adults (aged 50-64 years) are less likely to complete CRC screening than those age 65 years or older. 3 Differences in CRC screening rates also are found by education, socioeconomic status, insurance status, state/region of residence, and immigration status. 3, 4 Prior research has demonstrated that patients have clear preferences for certain CRC test modalities. 5 Patients who are provided with a choice to complete either SBT or colonoscopy are more likely to complete a screening test compared with those provided only a recommendation for colonoscopy. 6 Furthermore, when individuals' test preferences are not taken into account (i.e., their health care provider orders a different screening test), patients' satisfaction with the CRC screening decision making process, their CRC screening intentions, and their screening rates are reduced. 7 To provide patient-centered care, CRC screening test preference should be considered. However, relatively few studies have assessed CRC test preference. In addition, it is possible that patients with specific characteristics may prefer one test over another. Further, it may be that patients with specific sociodemographic and/or health care experience characteristics are less likely than others to receive a CRC test concordant with their preferred screening test.
The current study uses data from a large randomized intervention trial in which 1196 age-appropriate women who were not up-to-date with CRC screening guidelines were randomized to receive 1 of 3 tailored CRC screening educational interventions (i.e., Web intervention, phone intervention, or Web and phone intervention) or usual care. 8 Women randomized to 1 of the 3 tailored intervention groups (n = 891) were asked to report their CRC screening test preference during intervention receipt (approximately 2 months after baseline). 8 At baseline, 1139 women (95.2%) were determined to be of average risk and 56 (4.7%) were at increased risk for CRC (due to family history), with 1 missing (0.1%). 8 Most individuals in the United States who are up-todate with CRC screening have completed endoscopy (colonoscopy or sigmoidoscopy), 3 and prior studies have suggested that most individuals prefer endoscopy. 9 Thus, we were interested in further examining preferences and completion as they relate to the intervention and participants' baseline sociodemographic, health care experience, and health belief characteristics. The current study uses data only from average-risk participants because the focus is on concordance between preference and test receipt, and average-risk individuals can choose which test they prefer, whereas colonoscopy is recommended for individuals at increased risk. 2 Specific research questions addressed in the current study include the following: 
Methods
Study procedures and participant flow have been described previously. 8 Study procedures were approved by the Indiana University-Purdue University Indianapolis Institutional Review Board and were compliant with the Health Insurance Portability and Accountability Act. Participants were patients within 2 health care systems and were eligible if they were female, ages 50 to 75 years, not currently up-to-date with CRC screening recommendations, and had Internet access. Women were ineligible if they had a personal history of CRC, colorectal polyps, or inflammatory bowel disease or had any medical conditions that would prohibit CRC screening. Of those assessed for eligibility (N = 8355), 7159 were excluded because they 1) opted out prior to being contacted by the study team (n = 801), 2) were contacted but opted out prior to determining eligibility (n = 2274), 3) were ineligible (n = 3564), 4) declined to participate (n = 431), or 5) were consented but unable to be contacted for the baseline interview (n = 89). 8 Following informed consent and completion of a baseline interview, participants (n = 1196) were randomized to 1 of 4 groups, including 3 intervention groups and usual care. 8 Some women were also not up-to-date with mammography; these women also received mammography education via the same intervention method through which they received CRC screening education (Champion et al., under review; Champion et al., in preparation). The current study focuses on data captured as part of the CRC screening intervention. However, because of the multibehavioral focus of the parent study (on both CRC and breast cancer screening), only women were enrolled. Here we present preference concordance data on CRC screening, as women at average risk for the disease have a choice between screening modalities (as opposed to breast cancer screening, for which mammography is the only recommended screening modality).
Data were collected at baseline, during, and directly following intervention receipt (approximately 2 months after baseline), and at 6 months postintervention (CRC screening receipt). Participants received a $20 gift certificate at each data collection time point.
Interventions
The 3 tailored interventions were informed by the Health Belief Model, Transtheoretical Model, and Likelihood Persuasion Behavioral Theory. 8 Participants randomized to the tailored Web-only intervention group completed an interactive Web-based computer program that included video vignettes, graphs, animations of screening tests, and tailored messages based on the participants' characteristics and health beliefs. The concept behind the storyline of the Web program was a talk show about health (called ''Health Matters with Barbara Daniels''), which included actors portraying a talk show host (called ''Barbara Daniels'') and 2 guests (one woman portraying an elementary school teacher/community advocate and another woman portraying a physician). At times, the host addressed the guests on the show and at other times addressed the study participant by directly looking at the camera and providing tailored information and/or asking questions to which the participant could respond by making a selection on their computer. Tailored messages were populated based on participants' responses to demographic and health beliefs questions throughout the program. The average time that it took to complete the Web program was 14.69 min for the Web-only arm and 13.71 min for the Web + phone arm.
The phone counseling session was guided by a computer program that populated tailored messages based on participant characteristics and responses to health belief items. Those in the tailored phone counseling-only group interacted with 1 of 6 trained interventionists via phone (average time = 19 min). Women in the Web + phone intervention group received both the interactive Web-based computer program and tailored phone counseling. Women in the Web + phone intervention group were asked to complete the Web intervention prior to receiving the phone intervention (average time of phonecounseling portion = 19 min). Seven interventionists completed the phone counseling portion of the intervention for the Web + phone group (6 of whom also provided phone counseling to participants in the phone counseling-only group).
Women randomized to the Web-only, phone-only, or Web + phone intervention groups were asked to report their preference for a CRC screening test during receipt of the intervention. Women in the usual-care group were not asked to report their preference. Thus, they were excluded from the current analyses.
Measures
Health Belief Model variables. At baseline, participants completed measures used in prior research assessing perceived CRC risk (e.g., ''I am likely to get colon cancer sometime during my life''), perceived benefits of CRC screening (e.g., ''Having regular colon tests will help me find colon cancer when it is small and can be cured''), perceived barriers to SBT (e.g., ''Collecting a stool sample is unpleasant''), perceived barriers to colonoscopy (e.g., ''Having to take the special medicine to clean out my bowel before the test would be hard''), self-efficacy for completing SBT (e.g., ''How sure are you that you could complete each of the following steps to get a stool blood test? . . . Get a stool blood test kit from my doctor''), and self-efficacy for completing colonoscopy (e.g., ''How sure are you that you could complete each of the following steps to get a colonoscopy? . . . Find transportation to have a colonoscopy''). 8, [10] [11] [12] The Health Belief Model scales were originally developed for breast cancer screening but were adapted for CRC screening and demonstrated adequate content and construct validity in prior research.
12,13 Cronbach's alpha for the health belief model scales in the current study were as follows: 0.96 (perceived CRC risk), 0.71 (perceived benefits of CRC screening), 0.75 (perceived barriers to SBT), 0.85 (perceived barriers to colonoscopy), 0.93 (self-efficacy for completing SBT), and 0.90 (self-efficacy for completing colonoscopy).
Transtheoretical Model stage of change. At baseline, participants reported whether they were thinking about completing a colonoscopy in the next 6 months and whether they were thinking about completing an SBT in the next 6 months. Participants were categorized as being in the precontemplation stage for the specific CRC tests if they were not considering completing that CRC screening test in the next 6 months and in the contemplation stage if they were considering having that CRC screening test in the next 6 months, using measures from prior research. 8, [10] [11] [12] Knowledge. At baseline, 11 items from prior research assessed participants' knowledge of CRC and CRC screening tests (e.g., ''What is a small growth inside the colon that might turn into cancer called?'') and are based on the multiple dimensions of information shared in the intervention materials and in prior intervention studies conducted by the team.
8,10-12 The Cronbach's alpha for the knowledge scale in the current study was 0.50.
Fear. At baseline, 8 items assessed participants' level of fear regarding the development of cancer (''When I think about cancer, I get scared''). 8, 10, 14 The fear scale was originally designed to assess breast cancer fear and demonstrated adequate construct and content validity, 14 and it was adapted for general cancer fear. The Cronbach's alpha for the fear measure in the current study was 0.93.
Fatalism. At baseline, 11 items assessed the extent to which one holds the belief that death is inevitable following a cancer diagnosis (e.g., ''If a woman gets cancer, that's the way she was meant to die''). [15] [16] [17] Cronbach's alpha in the current study for fatalism was 0.87. Psychometric testing of the fatalism scale has been reported previously.
15-17
Sociodemographics and health care experiences. At baseline, participants responded to variables assessing sociodemographic characteristics including age, race, education, income, marital status, insurance status, and height and weight (to determine body mass index [BMI]). 8 In addition, participants responded to an item assessing the number of times they had seen a health care provider in the past year, an item assessing whether a health care provider had ever previously recommended the participant complete a colonoscopy, an item assessing whether a health care provider had ever previously recommended the participant complete an SBT, an item about prior completion of an SBT, and an item about prior completion of a colonoscopy. 8 CRC test preference. Test preference was solicited toward the end of each tailored intervention but before the full intervention was completed. Participants responded to a single item about their preferred CRC test modality with options that included SBT and colonoscopy. Individuals selecting both SBT and colonoscopy were coded as having no preference. 8 Individuals who did not respond with a preference in the phone or Web + phone intervention groups were coded as missing, unless they were in the Web + phone intervention group and had a stated CRC test preference during completion of 1 of the intervention components. As the item assessing test preference occurred during the intervention following receipt of information about the various test modalities, this item was asked once during the course of the study (postbaseline but prior to the follow-up interview) for most participants. Individuals in the Web + phone group had the opportunity to answer the preference item during both the Web and phone counseling portions of the intervention. Therefore, their Web intervention response was used for preference coding as they were asked to complete the Web portion of the intervention prior to the phone counseling portion of the intervention. Furthermore, as this item was asked only during receipt of each of the tailored interventions, those in usual care did not have the opportunity to indicate their test preference.
Statistical Analyses
Among women randomized to 1 of the 3 intervention groups (n = 891), 38 were at increased risk for CRC, and risk status was missing for 1 person. These participants were excluded from the current analyses. In addition, average-risk individuals in the intervention groups with available data who were lost to follow-up prior to intervention receipt or who failed to complete their tailored intervention (and therefore did not report a test preference; n = 240) and those who reported no test preference (n = 9) were excluded from the current analysis, resulting in 603 participants. Figure 1 portrays the participant flow for the current analyses. Ad hoc analyses revealed that individuals randomized to the Web-only group were significantly more likely to be excluded from analyses because of either not completing the tailored intervention or reporting no preference (P \ 0.001).
Receipt of screening by 6 months post-baseline was defined by a ''best estimate'' screening receipt variable. Participants were considered screened if they reported ''yes'' to the screening question in the self-report interview or a completed test was documented in medical records. They were coded as not screened otherwise or missing if both self-report and medical records were missing. 8 Medical record data on individuals who completed both SBT and colonoscopy were used to determine the date of receipt of each of the tests (if recorded), to examine which test the participant completed first. This method was used for the small number of individuals (n = 27) who completed both SBT and colonoscopy in order to define concordance (the first completed test Dates of the screening test were available for 19 of the 27 (70%) participants completing both tests. In cases in which 1 or more of these dates were missing (n = 8), it was decided to code those individuals as having had SBT first (given typical clinical practice of SBT first, followed by diagnostic colonoscopy if the SBT is positive). A concordance variable was created to indicate individuals who received a CRC screening test concordant with their stated preference (concordance was coded as 1, discordance was coded as 0).
Pearson chi-square tests (or 2-sided Fisher's exact test for variables having sparse expected cell counts) and 2-sided independent-groups t tests (or Wilcoxon rank-sum test for variables with a nonnormal distribution) were used to compare preference groups and concordance/discordance groups on categorical and continuous variables, respectively. Because individuals randomized to the Web + phone intervention group were asked about preference twice, their first reported preference was used in statistical analyses. Finally, all variables associated with receipt of a concordant screening test at P \ 0.25 in univariate analyses were further assessed in multivariable logistic regression analyses. Statistical analyses were performed using R software 18 with Arsenal 19 and Tidyverse 20 packages. A P value of \0.05 was considered statistically significant for all analyses. The funding source had no role in the study.
Results
Overall intervention results have been reported previously. 8 Specifically, the percentages of women adherent to any CRC screening test 6 months postintervention were as follows: phone only = 52.5%, Web only = 22.7%, Web + phone = 44.4%, usual care = 24.6%. 8 Of the 603 women who were at average CRC risk and reported a test preference, 386 (64%) preferred SBT and 217 (36%) preferred colonoscopy. Of the 603 women, 28% were assigned to the Web-only group, 36% were assigned to the phone-only group, and 37% were assigned to the Web + phone group. Demographics for the total sample and by study arm are presented in Table  1 . Most were white (88%), married (62%), had an annual household income greater than $30 000 (71%), and had completed some college, a 4 -year college degree, or a graduate degree (74%). In addition, most (89%) had health insurance and had seen a health care provider in the past year (93%). Approximately 40% had ever completed a CRC screening test previously (i.e., either SBT or colonoscopy). The average age was 58.6 years (range, 50-75 years).
Of the sociodemographic characteristics and health care experiences, only age was associated with CRC test preference (Table 2) . Specifically, participants who preferred colonoscopy were significantly younger compared with those preferring SBT (P = 0.03). BMI was specified as a categorical variable with 3 levels because it provides well-established meaningful categories and was more strongly associated with concordance than continuous BMI (P = 0.28 v. P = 0.93). A number of health belief variables were associated with CRC test preference (Table 2) in the directions that would be expected theoretically. Stages of change at baseline for SBT and colonoscopy were significantly associated with test preference. As expected, individuals who were in the contemplation stage for SBT were more likely to prefer SBT (78.8%, P = 0.002), and those who were in the contemplation stage for colonoscopy were more likely to prefer colonoscopy (66.2%, P \ 0.001). Participants preferring colonoscopy had higher levels of perceived benefits of CRC screening (P = 0.008), lower barriers to both colonoscopy (P \ 0.001) and SBT (P = 0.022), and higher self-efficacy for colonoscopy (P \ 0.001). None of the other associations were significant.
The overall CRC intervention effect and predictors of CRC screening test completion have been previously reported. 8 Among those in the 3 tailored intervention groups, 230 participants completed a CRC screening test at 6 months postintervention; of these, 193 women (84%) completed a test concordant with their preference, while the remaining 37 (16%) completed a test discordant with their preferred test. Among 230 CRC screening completers, 164 (71.3%) women reported a preference for SBT, and of those, 129 (78.7%) completed a SBT, 14 (8.5%) completed a colonoscopy, and 20 (12.8%) completed both a SBT and a colonoscopy. Of those who completed both tests, 11 completed a SBT first (concordant with preference), 1 completed a colonoscopy first (discordant with preference), and for 8 participants, the dates for test completion were unknown. Among 230 CRC screening completers, 66 (28.7%) women reported a preference for colonoscopy, and of those, 37 (56.1%) completed a colonoscopy, 23 (34.8%) completed SBT, and 6 (9.1%) individuals completed both a SBT and a colonoscopy. Of those who completed both tests, 1 completed a colonoscopy first (concordant with preference), 2 completed a SBT first (discordant with preference), and for 3 participants, the dates of test completion were unknown. As previously noted, individuals for whom test dates were not known were coded as having completed SBT prior to colonoscopy, and concordance was coded accordingly. Among those who did not complete a CRC screening test 6 months post-intervention (n = 290), 170 (59%) preferred SBT and 120 (41%) preferred colonoscopy.
In multivariable logistic regression analyses, age, intervention group, and insurance status were significantly associated with receipt of a preference-concordant test (see Table 3 ). Specifically, older women were more likely than younger women to complete a preference-concordant test (odds ratio [OR] = 1.9 per 5-year increase, P = .01). In addition, women with health insurance were more likely to complete a preference-concordant test (OR = 0.2, P \ 0.05) than those without health insurance. Finally, women in the phone-only group were significantly more likely to receive a concordant test compared with those in the Webonly (OR = 7.9, P = 0.002) and Web + phone (OR = 6.4, P = 0.001) groups. This suggests that the phone-only intervention was superior in promoting the receipt of a preference-concordant test.
Discussion
The current study sought to understand the characteristics of individuals who preferred one CRC screening modality over another, the percentage of women receiving a preference-concordant CRC screening test following receipt of 1 of 3 tailored interventions, and the characteristics of participants receiving a preference-concordant test receipt while controlling for covariates. Findings revealed significant differences in test preference by age, baseline stage of change for SBT, baseline stage of change for colonoscopy, perceived benefits of CRC screening, perceived barriers to SBT, perceived barriers to colonoscopy, and self-efficacy for colonoscopy. The finding that younger age was significantly associated with a preference for colonoscopy is contrary to a prior randomized controlled trial (RCT) in which Schroy and colleagues 21 found no significant independent associations between demographic factors and preference for SBT versus colonoscopy. In our study, younger individuals (compared with older individuals) preferred the more invasive screening test (colonoscopy). Similar to the findings regarding preference for colonoscopy in our study, Hawley and colleagues 9 found that preference for endoscopy (either colonoscopy or sigmoidoscopy) was associated with self-efficacy, stage of change, and perceived benefits. However, contrary to the findings of the current study, Hawley and colleagues also found that preference for endoscopy was associated with physician recommendation and greater CRC worry. In the current study, physician recommendation was not associated with preference for either test, nor was cancer fear or cancer fatalism. Hawley and colleagues 9 also found that preference for SBT was associated with SBT self-efficacy, which was not found in the current study.
Differences in test preference between our study findings and those in prior literature may be due to differences in sociodemographic characteristics between studies as well as potential change in awareness of SBT and/or changes in preferences over time. In the current study, participants were not asked to report reasons for preferring one test over another. However, Schroy and colleagues 21 reported that among those who preferred colonoscopy, test accuracy was an important factor in their choice. In addition, those who preferred SBT cited worry about discomfort, inconvenience, and bowel preparation as factors influencing their test preference. Ultimately, however, those preferring colonoscopy were more likely to have a screening test ordered in that prior study.
Of those women in the current study who completed a screening test at 6 months post-intervention, 84% completed a preference-concordant test. Each of the tailored interventions presented both SBT and colonoscopy as potential screening modalities for women at average risk. After participants specified a preferred CRC test during the intervention, the remaining intervention content was then focused on reducing barriers and providing access to their preferred test. Rates of preference-concordance testing in the current study were markedly higher than those found in a prior RCT featuring a CRC screening decision aid. 21 Schroy and colleagues 21 found that while 95% of participants had a test preference, only 59% of tests ordered were concordant with patient preference. Similarly, Hawley and colleagues 9 found that only 50% of participants received a preference-concordant test. The high rates of completion of preference-concordant tests in the current study may be due to both the high rates of preference for SBT and the ability to have an SBT mailed directly to one's home at the conclusion of the tailored phone intervention portion (i.e., the phoneonly or Web + phone intervention arms). At the conclusion of the interventions that included the phone counseling (i.e., the phone-only or Web + phone intervention arms), individuals who preferred colonoscopy were able to receive assistance with scheduling a colonoscopy. In the Web intervention, individuals indicating that they were interested in completing either an SBT or colonoscopy were provided with their provider's office phone number and asked to call either to have an SBT mailed to their home or to have a colonoscopy scheduled (depending on their stated preference).
In the current study, older age, receipt of the tailored phone counseling intervention, and insurance status were significantly associated with receipt of a preferenceconcordant test in multivariable logistic regression analyses. Participants who preferred SBT were offered the opportunity to have a kit mailed to their home at the end of the intervention (when receiving the phone intervention components) or were asked to call their providers' office about having a kit mailed to them (when receiving the Web intervention). As age was associated with both preference of SBT and receipt of a preference-concordant test, older participants may have completed a preferenceconcordant test due to being given the opportunity to complete this less-invasive test (compared with colonoscopy). Older individuals also may be more likely than younger individuals to have had multiple conversations with providers about CRC screening over the years, and because of these discussions, they may have been more resolved in their decision about what screening test was right for them. Most of the participants in the current study had health insurance. However, having insurance was significantly associated with receipt of a preferenceconcordant test, suggesting that individuals with insurance might be able to ultimately access their preferred option more readily than uninsured individuals.
The finding that individuals who receive the phone counseling intervention only are more likely to receive a preference-concordant screening test was unexpected. In the current study, individuals in the phone counseling intervention group and the Web + phone intervention group had the opportunity to discuss the test options with a live person. In addition, although the phonecounseling script and the Web intervention script generally presented the same information, phone interventionists had the opportunity to answer participant questions in both groups receiving the phone-counseling component. Thus, one would expect that the completion rates of a preference-concordant test would have been similar between these 2 intervention groups. Pairwise comparisons and multivariable analyses confirmed that individuals in the phone counseling-only group were more likely to receive a preference-concordant test. However, in ad hoc analyses, we found that the phone counseling-only group reported a higher baseline stage of change for SBT as well as higher preference for SBT. This may have contributed to our findings that women in the phone counseling-only group received preference-concordant tests at a higher rate. 8 
Implications for Practice
Although satisfaction data (satisfaction with either the intervention or health care) were not collected in the current study, prior research suggests that having one's provider order a CRC screening test that is preferenceconcordant is associated with satisfaction, screening intentions, and test completion. 7 To provide patientcentered care and promote informed decision making, health care providers should educate all average-risk patients about the availability of multiple CRC screening test modalities, discuss the pros and cons of the tests, discuss individuals' test preferences, and facilitate patients receiving their preferred test. In addition, providers should consider that many individuals, especially older adults, may prefer the less-invasive CRC screening modality of SBT and support this preference and their decision to complete SBT.
Strengths
Strengths of the study include the large sample size and randomized controlled design. In addition, all participants were due for CRC screening, most had health insurance, and most had seen a health care provider in the past year, making this a group of women who were not up-todate at baseline, despite having access to health care.
Limitations and Future Directions
Several limitations should be noted. First, study participants were predominately white women. Prior literature has found racial/ethnic differences in patient preferences. 5, 6 For example, white patients have been found to be more likely to adhere to colonoscopy recommendations, whereas nonwhite patients have been found to be more likely to adhere to SBT recommendations. 6 Although the current study found no racial differences between CRC screening test preference, this may have been due to the small numbers of nonwhite participants. Second, all participants were from a single Midwestern state, enrolled in an RCT aimed at promoting CRC screening, and most had health insurance. Therefore, generalizability may be limited. Additional research is needed among individuals from more diverse racial and ethnic backgrounds, among those from different states and regions of the United States, and among individuals who may be under-or uninsured. Third, women randomized to the Web-only intervention group were significantly more likely to be excluded from the analyses because of not completing the tailored intervention or reporting no preference (P \ 0.001). It may be that individuals who were randomized to the Web intervention felt less compelled to complete the intervention as they were not directly interacting with another human, whereas those in the intervention arms that received the phone counseling component knew they would be receiving phone counseling with a live person. Finally, we asked about test preference during intervention receipt (not at baseline or at follow-up) and thus are not able to capture potential changes in preference over time or in the control group. Future intervention trials might capture test preference at multiple time points and for all intervention groups.
Conclusions
To provide patient-centered care and to facilitate informed decision making, it is important that patients' preferences be considered and supported. Women who were not currently up-to-date with CRC screening received 1 of 3 tailored CRC educational interventions. Most women preferred SBT, which may indicate a shift in preference trends from prior research studies in which colonoscopy was preferred. Furthermore, among those women completing a CRC screening test post-intervention, most completed a preference-concordant test, suggesting that high rates of preference-concordance test receipt can be achieved. Individuals who received the tailored phone counseling-only intervention, those with health insurance, and older participants were significantly more likely to receive a screening test concordant with their stated preference. Findings have important implications for future research and practice.
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